Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Australia’s largest health insurer Medibank buys primary care chain Better Medical

Medibank, the largest private health insurer in Australia, is buying Better Medical, a 61-clinic primary care chain, from private equity firm Livingbridge, for A$159 million (~$103 million). This is part of a wider trend of vertical consolidation by insurers within Australia’s private healthcare market, which is raising concerns amongst many in the sector that it could lead to harmful cost cutting.
November 6, 2025

CMA greenlights PHP/Assura merger

The UK’s competition authority (the CMA) has decided to allow the merger of Assura and Primary Healthcare Properties (PHP), the only two major UK healthcare REITs focused on primary care clinics, bringing the creation of a giant primary care REIT holding about £6 billion (~€7 billion) worth of property and about 20% of the UK’s primary care practices one step closer to realisation. 
November 5, 2025

Thermo Fisher buys clinical software company Clario for $9bn

Thermo Fisher, a US life sciences and clinical research company listed on the New York Stock Exchange, has acquired Clario, a US company that provides software for clinical trials, from private equity firms Nordic Capital and Astorg Partners, for around $9 billion.
October 30, 2025

Healthcare Activos spends €150m on seven facilities

Spain-based healthcare real estate investor Healthcare Activos has acquired seven facilities, two of which are newbuilds. This brings Activos’ total assets under management to €1.3 billion. HBI caught up with Alberto Fernandez, Co-CEO, to understand how these acquisitions fit in with the investor’s long term strategy.
October 30, 2025

Bavarian Nordic board tries to push shareholders to accept Nordic Capital-led take-private

A consortium made up of two private equity firms, Nordic Capital and Permira, is trying to buy out Danish vaccine maker Bavarian Nordic and take it off the stock market. Bavarian Nordic’s board is keen for shareholders to accept, but not enough shareholders accepted the initial offer made in August. Nordic Capital and Permira have now made a sweetened offer, and lowered the percentage of shares that have to accept it in order for the offer to proceed from 75% to two thirds of the total.
October 23, 2025

EQT exits ImCheck Therapeutics following Ipsen’s €1 billion acquisition deal

EQT Life Sciences, the healthcare investment arm of Swedish private equity firm EQT, has exited Marseille-based biotech ImCheck Therapeutics. ImCheck, which develops immuno-oncology therapies targeting butyrophilins, a novel family of immune-regulating proteins, has agreed to be acquired by Paris-headquartered biopharmaceutical company Ipsen in a deal worth up to €1 billion. The deal underscores growing interest in European immunotherapy innovation, driven by patent cliff pressures, favourable valuation dynamics compared to US assets, and Europe’s maturing research ecosystem, which now produces around 40% of global scientific citations.
October 23, 2025

Bupa acquires third London hospital

British multinational health insurer Bupa is buying King Edward VII’s Hospital, a 56-bed facility in the Harley Street area in London. This follows the recent acquisition of New Victoria Hospital, a 33-bed facility in Kingston Upon Thames. Both acquisitions are driven by Bupa’s strategic intent to keep 40% of referrals within its provider network. However, we hear Bupa may struggle to attract the consultants, and therefore enough patients, that would be required to achieve this.
October 23, 2025
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us